Showing 1 posts of 1 posts found.
UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
Europa Biosite enters Czech market with acquisition of diagnostics distributor
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials